Both in Pharmaceuticals
Cartesian Therapeutics vs Niagen Bioscience
Over the past year RNAC returned −19.6% and NAGE returned −65.1%; their daily moves had a correlation of 0.18.
RNAC −19.6% NAGE −65.1%Growth of $1, one year, split-adjusted
| Metric | RNAC | NAGE |
|---|---|---|
| Price | $6.45 | $2.52 |
| Market cap | $195.1M | $199.4M |
| Today | −0.15% | +0.80% |
| 1 month | −10.9% | −14.6% |
| 6 months | −0.3% | −47.1% |
| Year to date | −10.5% | −60.4% |
| 1 year | −27.1% | −66.8% |
| Revenue growth (YoY) | −100.0% | −4.3% |
| Gross margin | — | 64.8% |
| Net margin | — | 3.2% |
| P/E (TTM) | — | 12.5× |
| Price / sales | 132.1× | 1.5× |
| Net cash | $94.8M | $66.7M |
| Dividend yield | — | — |
| Volatility (60d) | 49.5% | 47.1% |
| Short % of float | 15.6% | 8.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).